BRUNSWICK CORP (BC) Fundamental Analysis & Valuation

NYSE:BC • US1170431092

Current stock price

82.43 USD
+1.2 (+1.48%)
At close:
82.43 USD
0 (0%)
After Hours:

This BC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. BC Profitability Analysis

1.1 Basic Checks

  • In the past year BC was profitable.
  • In the past year BC had a positive cash flow from operations.
  • BC had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years BC had a positive operating cash flow.
BC Yearly Net Income VS EBIT VS OCF VS FCFBC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

1.2 Ratios

  • BC has a Return On Assets (-2.58%) which is in line with its industry peers.
  • BC's Return On Equity of -8.45% is on the low side compared to the rest of the industry. BC is outperformed by 61.29% of its industry peers.
  • BC has a Return On Invested Capital of 5.91%. This is in the better half of the industry: BC outperforms 64.52% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for BC is in line with the industry average of 7.55%.
Industry RankSector Rank
ROA -2.58%
ROE -8.45%
ROIC 5.91%
ROA(3y)2.15%
ROA(5y)5.62%
ROE(3y)6.19%
ROE(5y)16.54%
ROIC(3y)8.7%
ROIC(5y)11.18%
BC Yearly ROA, ROE, ROICBC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

1.3 Margins

  • With a decent Operating Margin value of 5.83%, BC is doing good in the industry, outperforming 74.19% of the companies in the same industry.
  • BC's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 24.84%, BC is doing worse than 61.29% of the companies in the same industry.
  • BC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 5.83%
PM (TTM) N/A
GM 24.84%
OM growth 3Y-25.84%
OM growth 5Y-14.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.01%
GM growth 5Y-2.03%
BC Yearly Profit, Operating, Gross MarginsBC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

4

2. BC Health Analysis

2.1 Basic Checks

  • BC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • BC has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for BC has been reduced compared to 5 years ago.
  • Compared to 1 year ago, BC has an improved debt to assets ratio.
BC Yearly Shares OutstandingBC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
BC Yearly Total Debt VS Total AssetsBC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • An Altman-Z score of 3.11 indicates that BC is not in any danger for bankruptcy at the moment.
  • BC's Altman-Z score of 3.11 is fine compared to the rest of the industry. BC outperforms 64.52% of its industry peers.
  • BC has a debt to FCF ratio of 5.30. This is a neutral value as BC would need 5.30 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 5.30, BC is in line with its industry, outperforming 54.84% of the companies in the same industry.
  • BC has a Debt/Equity ratio of 1.11. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 1.11, BC is not doing good in the industry: 70.97% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 5.3
Altman-Z 3.11
ROIC/WACC0.67
WACC8.86%
BC Yearly LT Debt VS Equity VS FCFBC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 1.44 indicates that BC should not have too much problems paying its short term obligations.
  • The Current ratio of BC (1.44) is worse than 61.29% of its industry peers.
  • A Quick Ratio of 0.61 indicates that BC may have some problems paying its short term obligations.
  • BC has a worse Quick ratio (0.61) than 74.19% of its industry peers.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 0.61
BC Yearly Current Assets VS Current LiabilitesBC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

4

3. BC Growth Analysis

3.1 Past

  • The earnings per share for BC have decreased strongly by -28.29% in the last year.
  • Measured over the past years, BC shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.40% on average per year.
  • Looking at the last year, BC shows a small growth in Revenue. The Revenue has grown by 2.40% in the last year.
  • BC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.29% yearly.
EPS 1Y (TTM)-28.29%
EPS 3Y-31.13%
EPS 5Y-8.4%
EPS Q2Q%141.67%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y-7.66%
Revenue growth 5Y4.29%
Sales Q2Q%15.49%

3.2 Future

  • BC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.86% yearly.
  • Based on estimates for the next years, BC will show a small growth in Revenue. The Revenue will grow by 5.76% on average per year.
EPS Next Y34.17%
EPS Next 2Y28.38%
EPS Next 3Y27.67%
EPS Next 5Y27.86%
Revenue Next Year9.16%
Revenue Next 2Y7.11%
Revenue Next 3Y6.77%
Revenue Next 5Y5.76%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BC Yearly Revenue VS EstimatesBC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B
BC Yearly EPS VS EstimatesBC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

5

4. BC Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 25.21 indicates a quite expensive valuation of BC.
  • Compared to the rest of the industry, the Price/Earnings ratio of BC indicates a somewhat cheap valuation: BC is cheaper than 61.29% of the companies listed in the same industry.
  • BC's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.95.
  • BC is valuated rather expensively with a Price/Forward Earnings ratio of 18.79.
  • Based on the Price/Forward Earnings ratio, BC is valued a bit cheaper than 64.52% of the companies in the same industry.
  • BC is valuated cheaply when we compare the Price/Forward Earnings ratio to 38.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 25.21
Fwd PE 18.79
BC Price Earnings VS Forward Price EarningsBC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • 67.74% of the companies in the same industry are more expensive than BC, based on the Enterprise Value to EBITDA ratio.
  • 70.97% of the companies in the same industry are more expensive than BC, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 13.54
EV/EBITDA 11.92
BC Per share dataBC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • BC's earnings are expected to grow with 27.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.74
PEG (5Y)N/A
EPS Next 2Y28.38%
EPS Next 3Y27.67%

6

5. BC Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.28%, BC has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 1.26, BC pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.81, BC pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.28%

5.2 History

  • The dividend of BC is nicely growing with an annual growth rate of 11.59%!
  • BC has been paying a dividend for at least 10 years, so it has a reliable track record.
  • BC has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)11.59%
Div Incr Years13
Div Non Decr Years17
BC Yearly Dividends per shareBC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • BC has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • The dividend of BC is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-82.01%
EPS Next 2Y28.38%
EPS Next 3Y27.67%
BC Yearly Income VS Free CF VS DividendBC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

BC Fundamentals: All Metrics, Ratios and Statistics

BRUNSWICK CORP

NYSE:BC (4/20/2026, 8:04:00 PM)

After market: 82.43 0 (0%)

82.43

+1.2 (+1.48%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryLeisure Products
Earnings (Last)01-29
Earnings (Next)04-30
Inst Owners104.42%
Inst Owner Change0.06%
Ins Owners1.01%
Ins Owner Change0.11%
Market Cap5.37B
Revenue(TTM)5.36B
Net Income(TTM)-137.30M
Analysts77.14
Price Target92.13 (11.77%)
Short Float %6.39%
Short Ratio4.37
Dividend
Industry RankSector Rank
Dividend Yield 2.28%
Yearly Dividend1.72
Dividend Growth(5Y)11.59%
DP-82.01%
Div Incr Years13
Div Non Decr Years17
Ex-Date02-23
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.15%
Min EPS beat(2)-2.34%
Max EPS beat(2)10.64%
EPS beat(4)3
Avg EPS beat(4)41.04%
Min EPS beat(4)-2.34%
Max EPS beat(4)136.9%
EPS beat(8)4
Avg EPS beat(8)19.7%
EPS beat(12)5
Avg EPS beat(12)11.6%
EPS beat(16)7
Avg EPS beat(16)8.89%
Revenue beat(2)2
Avg Revenue beat(2)5.84%
Min Revenue beat(2)4.71%
Max Revenue beat(2)6.96%
Revenue beat(4)4
Avg Revenue beat(4)7.35%
Min Revenue beat(4)4.71%
Max Revenue beat(4)12.87%
Revenue beat(8)5
Avg Revenue beat(8)2.39%
Revenue beat(12)5
Avg Revenue beat(12)-0.29%
Revenue beat(16)6
Avg Revenue beat(16)-1.2%
PT rev (1m)2.08%
PT rev (3m)11.82%
EPS NQ rev (1m)0.81%
EPS NQ rev (3m)-41.32%
EPS NY rev (1m)0.46%
EPS NY rev (3m)1.57%
Revenue NQ rev (1m)0.29%
Revenue NQ rev (3m)0.66%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)3.24%
Valuation
Industry RankSector Rank
PE 25.21
Fwd PE 18.79
P/S 1
P/FCF 13.54
P/OCF 9.55
P/B 3.3
P/tB 59.9
EV/EBITDA 11.92
EPS(TTM)3.27
EY3.97%
EPS(NY)4.39
Fwd EY5.32%
FCF(TTM)6.09
FCFY7.38%
OCF(TTM)8.63
OCFY10.47%
SpS82.37
BVpS24.97
TBVpS1.38
PEG (NY)0.74
PEG (5Y)N/A
Graham Number42.8596 (-48%)
Profitability
Industry RankSector Rank
ROA -2.58%
ROE -8.45%
ROCE 8.04%
ROIC 5.91%
ROICexc 6.33%
ROICexgc 10.98%
OM 5.83%
PM (TTM) N/A
GM 24.84%
FCFM 7.39%
ROA(3y)2.15%
ROA(5y)5.62%
ROE(3y)6.19%
ROE(5y)16.54%
ROIC(3y)8.7%
ROIC(5y)11.18%
ROICexc(3y)9.5%
ROICexc(5y)12.37%
ROICexgc(3y)18.05%
ROICexgc(5y)24.22%
ROCE(3y)11.84%
ROCE(5y)15.22%
ROICexgc growth 3Y-29.65%
ROICexgc growth 5Y-20.68%
ROICexc growth 3Y-27.91%
ROICexc growth 5Y-19.68%
OM growth 3Y-25.84%
OM growth 5Y-14.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.01%
GM growth 5Y-2.03%
F-Score5
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 5.3
Debt/EBITDA 2.99
Cap/Depr 56.68%
Cap/Sales 3.09%
Interest Coverage 2.72
Cash Conversion 92.92%
Profit Quality N/A
Current Ratio 1.44
Quick Ratio 0.61
Altman-Z 3.11
F-Score5
WACC8.86%
ROIC/WACC0.67
Cap/Depr(3y)73.55%
Cap/Depr(5y)107.72%
Cap/Sales(3y)3.6%
Cap/Sales(5y)4.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.29%
EPS 3Y-31.13%
EPS 5Y-8.4%
EPS Q2Q%141.67%
EPS Next Y34.17%
EPS Next 2Y28.38%
EPS Next 3Y27.67%
EPS Next 5Y27.86%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y-7.66%
Revenue growth 5Y4.29%
Sales Q2Q%15.49%
Revenue Next Year9.16%
Revenue Next 2Y7.11%
Revenue Next 3Y6.77%
Revenue Next 5Y5.76%
EBIT growth 1Y-27.9%
EBIT growth 3Y-31.52%
EBIT growth 5Y-10.54%
EBIT Next Year85.06%
EBIT Next 3Y32.29%
EBIT Next 5Y23.77%
FCF growth 1Y50.11%
FCF growth 3Y26.07%
FCF growth 5Y-8.44%
OCF growth 1Y30.3%
OCF growth 3Y-1.38%
OCF growth 5Y-6.78%

BRUNSWICK CORP / BC Fundamental Analysis FAQ

What is the fundamental rating for BC stock?

ChartMill assigns a fundamental rating of 4 / 10 to BC.


What is the valuation status of BRUNSWICK CORP (BC) stock?

ChartMill assigns a valuation rating of 5 / 10 to BRUNSWICK CORP (BC). This can be considered as Fairly Valued.


Can you provide the profitability details for BRUNSWICK CORP?

BRUNSWICK CORP (BC) has a profitability rating of 3 / 10.


What is the expected EPS growth for BRUNSWICK CORP (BC) stock?

The Earnings per Share (EPS) of BRUNSWICK CORP (BC) is expected to grow by 34.17% in the next year.


Is the dividend of BRUNSWICK CORP sustainable?

The dividend rating of BRUNSWICK CORP (BC) is 6 / 10 and the dividend payout ratio is -82.01%.